NANTONG JINGHUA PHARMACEUTICAL CO LTD

Overview

NANTONG JINGHUA PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 9 active FDA Type II Drug Master Files, covering DABIGATRAN ETEXILATE MESYLATE; FLUCYTOSINE; FLUOROURACIL USP; INDOCYANINE GREEN; LETERMOVIR; LURASIDONE HYDROCHLORIDE.

API / Drug Master Files

NANTONG JINGHUA PHARMACEUTICAL CO LTD holds 9 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LETERMOVIRActive2025-01-21
• INDOCYANINE GREENActive2024-09-27
• DABIGATRAN ETEXILATE MESYLATEActive2018-06-29
• LURASIDONE HYDROCHLORIDEActive2017-08-18
• PHENOBARBITALActive2017-02-09
• PRAZIQUANTEL USPActive2015-04-15
• FLUCYTOSINEActive2011-07-14
• PRIMIDONEActive2008-05-08
• FLUOROURACIL USPActive2005-06-28
• MOXIFLOXACIN HYDROCHLORIDE USPInactive2014-10-31
• CELECOXIB USPInactive2013-12-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NANTONG JINGHUA PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.